China: CAR T-cell therapy, already in use for certain B-cell–driven autoimmune diseases such as lupus, has now demonstrated ...

Inflammation has to fight pathogens fast—but it can't get out of control. Researchers at the German Cancer Research Center ...

After JP Morgan, the company is focusing on getting ready to submit a biologics license application to the FDA for miv-cel in ...

Every time our body encounters a new disease-causing agent, a crucial defense system called adaptive immunity comes into play ...

An international research team has uncovered a critical link between common viral infections and multiple sclerosis (MS), ...

Eleven patients with refractory autoimmune hemolytic anemia (AIHA) were all brought into drug-free remission with CAR T-cell ...

A recent publication in Nature Medicine describes a novel immunotherapy targeting pancreatic cancer that has shown promising ...

Neurodegenerative diseases, traditionally viewed as driven by neuronal decline, are increasingly recognized to involve ...

As people with α-gal syndrome seek to boost awareness, researchers are looking to harness the molecule for new therapies ...

Scientists from the Institute of Molecular Genetics of the Czech Academy of Sciences, in collaboration with the Faculty of ...

For starters, she pointed out that standard CAR-T therapy involves a lymphodepletion regimen with cyclophosphamide and ...